Showing results (271-280 of 568) with videos related to

Sort By:
Pageof 57
Journal of Orthopaedic Translation|March 16, 2026
Cell-based therapies for intervertebral disc degeneration: Navigating the path from promise to clinical realityLei Shi, Lizhi Jiang, Tong Xing, et al.
Ebiomedicine|February 1, 2022
Contribution of ferroptosis and GPX4's dual functions to osteoarthritis progressionYu Miao, Yiwei Chen, Feng Xue, et al.
American Journal of Infection Control|February 11, 2017
A real-time surgical site infections surveillance mode to monitor surgery classification-specific, hospital-wide surgical site infections in a Chinese tertiary hospitalMingmei Du, Meng Li, Kexin Liu, et al.
Inflammation|October 14, 2018
Catalpol Inhibits Homocysteine-induced Oxidation and Inflammation via Inhibiting Nox4/NF-κB and GRP78/PERK Pathways in Human Aorta Endothelial CellsHuimin Hu, Changyuan Wang, Yue Jin, et al.
Peptides|April 24, 2012
Effect of JBP485 on obstructive jaundice is related to regulation of renal Oat1, Oat3 and Mrp2 expression in ANIT-treated ratsTao Liu, Xinjin Guo, Qiang Meng, et al.
Drug Metabolism and Pharmacokinetics|November 30, 2011
Peptide cotransporter 1 in intestine and organic anion transporters in kidney are targets of interaction between JBP485 and lisinopril in ratsXinjin Guo, Qiang Meng, Qi Liu, et al.
Nanoscale Research Letters|July 3, 2010
Nanoparticles of Poly(Lactide-Co-Glycolide)-d-a-Tocopheryl Polyethylene Glycol 1000 Succinate Random Copolymer for Cancer TreatmentYuandong Ma, Yi Zheng, Kexin Liu, et al.
Pharmaceutical Research|November 19, 2013
MDR1 and OAT1/OAT3 mediate the drug-drug interaction between puerarin and methotrexateQi Liu, Changyuan Wang, Qiang Meng, et al.
British Journal of Pharmacology|January 18, 2017
Potent effects of dioscin against pancreatic cancer via miR-149-3P-mediated inhibition of the Akt1 signalling pathwayLingling Si, Lina Xu, Lianhong Yin, et al.
Cardiovascular Diabetology|January 13, 2026
Joint assessment of insulin resistance surrogate indices and basal metabolic rate for primary prevention of cardiometabolic multimorbidity: evidence from the China Health and Retirement Longitudinal Study (2011-2020)Hurong Lai, Chao Deng, Caifeng Liao, et al.
Pageof 57